What if biotechnology could cure cancer?
Date and time
This is your chance to learn from a founder, investor, and serial entrepreneur in the biotech industry.
About this event
Forty percent of us will develop cancer in our lifetime. What if we found and treated cancer early? How many lives could it save? How much burden would it take off our healthcare system?
Join us for a special conversation between Sally-Ann Williams, CEO of Cicada Innovations, and Cyriac Roeding, Co-founder and CEO of Earli, as we discuss how biotechnology could transform cancer detection and treatment in the future. This in-person event will have Cyriac joining us virtually from California, and 3 Australian biotech startups will be presenting their innovation in-person. At the end of the event, you will have a chance to network with our broader deep-tech and health tech community.
About Earli
US-based Biotech engineering company Earli is developing “Synthetic Biopsy”, a unique technology that forces cancer cells to reveal themselves. Originally from Stanford University, the radically new technique makes cancer produce synthetic biomarkers not normally expressed in the human body. The platform allows clinicians to exactly locate early cancers so they can be targeted and treated.
In 2021, Earli announced a $40 million in Series A funding led by Khosla Ventures, along with coinvestors including Andreessen Horowitz, Sands Capital, and top individuals Jim Breyer, Shlomo Ben-Haim, and Marc Benioff. They are currently conducting Phase 1 clinical trials of their technology at sites in Sydney, Melbourne and Adelaide.
Cyriac Roeding is an entrepreneur and investor who builds companies on the intersection of the physical, engineering and digital worlds. He has previously built three companies, and is an investor in more than 20 startups and venture funds including a16z, Bond, Founders Fund, Greylock, IVP, ZhenFund. He was named a World Economic Forum Tech Pioneer and a Fortune 40 Under 40 Mobilizer.
This event is in partnership with the City of Sydney and South Eveleigh.
This event is part of the Visiting Entrepreneur Program, an annual City of Sydney initiative that connects international entrepreneurs with our local startup ecosystem. The 22 June – 1 July 2022 program will explore what might the future look like for cities, technology and innovation in FUTURE T.B.D. This year, we will question everything, from a travel guide to decarbonisation to the future possibilities of the Metaverse and global health game changers. See the full program at city.sydney/vep #VEPSyd
The 2022 edition of the Visiting Entrepreneur Program is kindly supported by Tech Central and the Greater Cities Commission.
